| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 1.85e-08 | 35 | 17 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 1.42e-07 | 153 | 17 | 5 | GO:0008194 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 7.01e-07 | 211 | 17 | 5 | GO:0016758 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 3.24e-06 | 288 | 17 | 5 | GO:0016757 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 2.21e-11 | 8 | 17 | 4 | GO:0070980 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 6.61e-11 | 10 | 17 | 4 | GO:0018879 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 1.56e-10 | 12 | 17 | 4 | GO:0052697 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.87e-09 | 21 | 17 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 4.67e-09 | 26 | 17 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 4.67e-09 | 26 | 17 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 2.05e-08 | 37 | 17 | 4 | GO:0042537 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 2.05e-08 | 37 | 17 | 4 | GO:0042178 | |
| GeneOntologyBiologicalProcess | androgen metabolic process | 2.29e-08 | 38 | 17 | 4 | GO:0008209 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 8.34e-08 | 52 | 17 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 3.68e-07 | 376 | 17 | 6 | GO:0008202 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 2.67e-06 | 286 | 17 | 5 | GO:0042445 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 4.65e-06 | 141 | 17 | 4 | GO:0006805 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 2.78e-05 | 222 | 17 | 4 | GO:0071466 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 5.03e-05 | 525 | 17 | 5 | GO:0009410 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | 1.41e-04 | 1064 | 17 | 6 | GO:0006082 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 1.75e-04 | 684 | 17 | 5 | GO:0010817 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | 2.39e-04 | 731 | 17 | 5 | GO:0032787 | |
| GeneOntologyBiologicalProcess | lipid localization | 9.98e-04 | 565 | 17 | 4 | GO:0010876 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | 1.18e-03 | 1035 | 17 | 5 | GO:0019752 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | 1.30e-03 | 1058 | 17 | 5 | GO:0043436 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 2.69e-08 | 40 | 17 | 4 | GO:0005640 | |
| GeneOntologyCellularComponent | nuclear membrane | 6.61e-06 | 349 | 17 | 5 | GO:0031965 | |
| GeneOntologyCellularComponent | nuclear envelope | 6.42e-05 | 560 | 17 | 5 | GO:0005635 | |
| GeneOntologyCellularComponent | organelle outer membrane | 6.45e-05 | 279 | 17 | 4 | GO:0031968 | |
| GeneOntologyCellularComponent | outer membrane | 6.63e-05 | 281 | 17 | 4 | GO:0019867 | |
| GeneOntologyCellularComponent | organelle envelope | 6.63e-04 | 1435 | 17 | 6 | GO:0031967 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | 2.97e-03 | 1293 | 17 | 5 | GO:0005789 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | 3.03e-03 | 1299 | 17 | 5 | GO:0098827 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | 3.33e-03 | 1327 | 17 | 5 | GO:0042175 | |
| HumanPheno | Hypergammaglobulinemia | 1.84e-05 | 86 | 4 | 3 | HP:0004435 | |
| HumanPheno | Hyperglobulinemia | 2.18e-05 | 91 | 4 | 3 | HP:0002852 | |
| HumanPheno | Increased circulating antibody concentration | 4.18e-05 | 113 | 4 | 3 | HP:0010702 | |
| HumanPheno | Interstitial pneumonitis | 6.27e-05 | 17 | 4 | 2 | HP:0006515 | |
| HumanPheno | Increased circulating IgA concentration | 2.13e-04 | 31 | 4 | 2 | HP:0003261 | |
| HumanPheno | Thyroiditis | 6.05e-04 | 52 | 4 | 2 | HP:0100646 | |
| HumanPheno | Celiac disease | 7.28e-04 | 57 | 4 | 2 | HP:0002608 | |
| HumanPheno | Abnormal circulating immunoglobulin concentration | 7.36e-04 | 295 | 4 | 3 | HP:0010701 | |
| HumanPheno | Immunoglobulin abnormality | 7.36e-04 | 295 | 4 | 3 | HP:0100032 | |
| HumanPheno | Abnormality of B cell physiology | 7.44e-04 | 296 | 4 | 3 | HP:0005372 | |
| HumanPheno | Abnormal lymphocyte physiology | 1.01e-03 | 328 | 4 | 3 | HP:0031409 | |
| HumanPheno | Abnormal leukocyte physiology | 1.01e-03 | 328 | 4 | 3 | HP:0033796 | |
| HumanPheno | Antinuclear antibody positivity | 1.16e-03 | 72 | 4 | 2 | HP:0003493 | |
| HumanPheno | Abnormality of humoral immunity | 1.22e-03 | 350 | 4 | 3 | HP:0005368 | |
| HumanPheno | Abnormal immunological laboratory finding | 1.28e-03 | 356 | 4 | 3 | HP:0003346 | |
| HumanPheno | Abnormal B cell morphology | 1.40e-03 | 367 | 4 | 3 | HP:0002846 | |
| HumanPheno | Hypotension | 2.65e-03 | 109 | 4 | 2 | HP:0002615 | |
| HumanPheno | Abnormal circulating IgA concentration | 3.31e-03 | 122 | 4 | 2 | HP:0410240 | |
| HumanPheno | Fatigue | 3.49e-03 | 500 | 4 | 3 | HP:0012378 | |
| Domain | UDPGT | 2.78e-09 | 21 | 17 | 4 | PS00375 | |
| Domain | UDPGT | 2.78e-09 | 21 | 17 | 4 | PF00201 | |
| Domain | UDP_glucos_trans | 2.78e-09 | 21 | 17 | 4 | IPR002213 | |
| Domain | FYVE | 3.12e-04 | 29 | 17 | 2 | SM00064 | |
| Domain | FYVE | 3.12e-04 | 29 | 17 | 2 | PF01363 | |
| Domain | Znf_FYVE-rel | 4.30e-04 | 34 | 17 | 2 | IPR017455 | |
| Domain | Znf_FYVE | 5.38e-04 | 38 | 17 | 2 | IPR000306 | |
| Domain | ZF_FYVE | 5.96e-04 | 40 | 17 | 2 | PS50178 | |
| Domain | G-protein_beta_WD-40_rep | 2.66e-03 | 85 | 17 | 2 | IPR020472 | |
| Domain | Znf_FYVE_PHD | 7.74e-03 | 147 | 17 | 2 | IPR011011 | |
| Domain | WD40_repeat_CS | 9.56e-03 | 164 | 17 | 2 | IPR019775 | |
| Pathway | REACTOME_PREDNISONE_ADME | 5.33e-09 | 23 | 14 | 4 | MM16639 | |
| Pathway | REACTOME_GLUCURONIDATION | 6.39e-09 | 24 | 14 | 4 | MM14599 | |
| Pathway | WP_GLUCURONIDATION | 7.61e-09 | 25 | 14 | 4 | MM15820 | |
| Pathway | REACTOME_GLUCURONIDATION | 7.61e-09 | 25 | 14 | 4 | M17787 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 7.61e-09 | 25 | 14 | 4 | M605 | |
| Pathway | WP_GLUCURONIDATION | 8.99e-09 | 26 | 14 | 4 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 1.23e-08 | 28 | 14 | 4 | M19580 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 4.91e-08 | 39 | 14 | 4 | MM15695 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 6.03e-08 | 41 | 14 | 4 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 8.08e-08 | 44 | 14 | 4 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 8.86e-08 | 45 | 14 | 4 | MM15694 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 1.48e-07 | 51 | 14 | 4 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.60e-07 | 52 | 14 | 4 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 2.02e-07 | 55 | 14 | 4 | M14933 | |
| Pathway | KEGG_RETINOL_METABOLISM | 3.74e-07 | 64 | 14 | 4 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 5.37e-07 | 70 | 14 | 4 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 6.02e-07 | 72 | 14 | 4 | M9257 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 2.96e-06 | 107 | 14 | 4 | MM14595 | |
| Pathway | REACTOME_DRUG_ADME | 3.19e-06 | 109 | 14 | 4 | M45012 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 3.19e-06 | 109 | 14 | 4 | M18788 | |
| Pathway | REACTOME_DRUG_ADME | 4.53e-06 | 119 | 14 | 4 | MM15692 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 5.02e-05 | 219 | 14 | 4 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 5.11e-05 | 220 | 14 | 4 | M10320 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 7.05e-04 | 183 | 14 | 3 | M39588 | |
| Pubmed | 1.37e-12 | 7 | 17 | 4 | 26074487 | ||
| Pubmed | 2.73e-12 | 8 | 17 | 4 | 32093886 | ||
| Pubmed | 9.70e-11 | 3 | 17 | 3 | 8333863 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 21679149 | ||
| Pubmed | 4.35e-06 | 66 | 17 | 3 | 19898482 | ||
| Pubmed | 6.29e-06 | 8 | 17 | 2 | 10748067 | ||
| Pubmed | 2.38e-05 | 116 | 17 | 3 | 30652415 | ||
| Pubmed | 1.08e-04 | 193 | 17 | 3 | 19343046 | ||
| Pubmed | 1.56e-04 | 38 | 17 | 2 | 20214802 | ||
| Pubmed | Identification of transcripts with enriched expression in the developing and adult pancreas. | 2.03e-04 | 624 | 17 | 4 | 18554416 | |
| Interaction | UGT2B28 interactions | 9.96e-09 | 6 | 17 | 3 | int:UGT2B28 | |
| Interaction | UGT2B10 interactions | 6.69e-06 | 5 | 17 | 2 | int:UGT2B10 | |
| Interaction | UGT2B11 interactions | 1.40e-05 | 7 | 17 | 2 | int:UGT2B11 | |
| Interaction | ART3 interactions | 2.68e-04 | 29 | 17 | 2 | int:ART3 | |
| Cytoband | 4q13.2 | 1.88e-07 | 31 | 17 | 3 | 4q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 3.03e-07 | 157 | 17 | 4 | chr4q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.30e-02 | 473 | 17 | 2 | chr17q21 | |
| GeneFamily | UDP glucuronosyltransferases | 7.99e-09 | 32 | 14 | 4 | 363 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 2.56e-04 | 31 | 14 | 2 | 81 | |
| GeneFamily | WD repeat domain containing | 1.70e-02 | 262 | 14 | 2 | 362 | |
| Coexpression | VANLOO_SP3_TARGETS_DN | 5.06e-09 | 103 | 17 | 5 | MM919 | |
| Coexpression | WENG_POR_TARGETS_LIVER_UP | 3.48e-08 | 53 | 17 | 4 | MM1203 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP | 5.91e-07 | 267 | 17 | 5 | MM984 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_DN | 9.82e-07 | 121 | 17 | 4 | MM935 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | 5.91e-06 | 190 | 17 | 4 | MM1311 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 7.39e-06 | 201 | 17 | 4 | MM1294 | |
| Coexpression | DESCARTES_ORGANOGENESIS_HEPATOCYTES | 1.76e-05 | 535 | 17 | 5 | MM3635 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4 | 5.16e-05 | 330 | 17 | 4 | MM1120 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | 1.78e-04 | 455 | 17 | 4 | MM1189 | |
| Coexpression | BOCHKIS_FOXA2_TARGETS | 1.97e-04 | 467 | 17 | 4 | MM1233 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP | 2.71e-04 | 199 | 17 | 3 | M4526 | |
| Coexpression | GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_UP | 2.75e-04 | 200 | 17 | 3 | M4458 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP | 2.75e-04 | 200 | 17 | 3 | M6524 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 3.45e-04 | 541 | 17 | 4 | MM1061 | |
| Coexpression | GUILLAUMOND_KLF10_TARGETS_UP | 4.76e-04 | 50 | 17 | 2 | M2485 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | 6.28e-04 | 634 | 17 | 4 | M40866 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Trm_Tgd|Liver / Manually curated celltypes from each tissue | 2.58e-05 | 154 | 17 | 3 | c6308074468235c88ef4ea43ab155d9f86cbf261 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-05 | 173 | 17 | 3 | 6d2ceba4f89a228600e2b40aba81bb0eb81578c0 | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-05 | 174 | 17 | 3 | 55cc8300489d11322724159ec7d0e1d32a702e91 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Pitx2_(Subthalamic_nucleus_(STN))-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.11e-04 | 69 | 17 | 2 | 10d5fccc1fa10ffc9051df42dd0e5046d97ec4af | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Pitx2_(Subthalamic_nucleus_(STN))|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.11e-04 | 69 | 17 | 2 | 9d7e911434c6b18327fa7adaec5c449e0c300919 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Signet-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.38e-04 | 82 | 17 | 2 | 73ddc0286bea35f6d283cea30000a541cc6543c7 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.17e-04 | 105 | 17 | 2 | 8d5528ae2bdba17e2474a7ca07fc8596d1b04647 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-03 | 130 | 17 | 2 | d47d4ff1263815896470d854d25306eb36919e70 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.10e-03 | 130 | 17 | 2 | ad57b210c96caedadc1027b4d7a56b1bc389b137 | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-03 | 139 | 17 | 2 | d96e5c17582f1576fa09d6bad35c418b6248448c | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D2|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-03 | 145 | 17 | 2 | 3a34c25ff77cd33fdca84742097cc7484066ebc4 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.49e-03 | 152 | 17 | 2 | 32634195048858ae84605c61e43c542d90f7cab5 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.49e-03 | 152 | 17 | 2 | 0eb185b2404f015efff1bd140e0c502d714720fb | |
| ToppCell | droplet-Fat-SCAT-30m-Myeloid-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-03 | 153 | 17 | 2 | 2731c3d4ac40ecc22108f8f3f45a069077159125 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Pld5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.63e-03 | 159 | 17 | 2 | a082e770fa757c4a1d3ed13d53f83297e36faf05 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.65e-03 | 160 | 17 | 2 | 50d4f867d021abcfeb49e6812bcfd5bb57466a31 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-A_(AT2)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.65e-03 | 160 | 17 | 2 | cf27b4ac4d0caa6f9b068dc8ea93472470a01a4d | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.65e-03 | 160 | 17 | 2 | 0f15f895f11dcabb73df79b26bfc4947f38435a7 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-A_(AT2)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.65e-03 | 160 | 17 | 2 | 731def6d82814ebac1a400bc7aea5f6da43ec960 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.65e-03 | 160 | 17 | 2 | 7d004bfe42707605b3851cb2319126acda4d4802 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.71e-03 | 163 | 17 | 2 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-2|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.71e-03 | 163 | 17 | 2 | 2dfd11f5803822ba01b92adf4395a3b3adda68f5 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.71e-03 | 163 | 17 | 2 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_C|TCGA-Thymus / Sample_Type by Project: Shred V9 | 1.71e-03 | 163 | 17 | 2 | 2dac87d15051151ccf193760ddd8b82534c3f922 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.73e-03 | 164 | 17 | 2 | beaa13a75c3bb72446c85084d75e9fe3f15fd3d4 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.73e-03 | 164 | 17 | 2 | d005cfd821b87548b075120bffe65a0be9860463 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-03 | 167 | 17 | 2 | 1bd27ffe381d26731b6d4cc5f29b27f1bac4473b | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.82e-03 | 168 | 17 | 2 | 16b517e3159ad6e6d25fd48f7d5f46e77b2b318d | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-03 | 168 | 17 | 2 | faaba5ac01c2ebe380f56559374a121979a85a13 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.82e-03 | 168 | 17 | 2 | e20e1936573fdde78426d7a4eb45c458d5c4dbb4 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Col27a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.88e-03 | 171 | 17 | 2 | d07e2c5f7d7f12c68860d4161d76372de174f1d8 | |
| ToppCell | control|World / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.88e-03 | 171 | 17 | 2 | 837c1186504f110ccf5b580d9cd4e50ca60c173f | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-03 | 172 | 17 | 2 | a9e65201ad9ab4f64251aba2c0bb3d8f9e0193b6 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-03 | 172 | 17 | 2 | 26006967d0c82f7bd9b36a18e97a1b93e856aa67 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.95e-03 | 174 | 17 | 2 | 110369f6b78de34a6d934b5b47cecd023347bc80 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.95e-03 | 174 | 17 | 2 | 65147b0f8c2ccadd5685430d31081520c157536a | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.97e-03 | 175 | 17 | 2 | c227fc5d1ccb69b82a96a6354913cafaf27d0eec | |
| ToppCell | facs-Skin-nan-18m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-03 | 176 | 17 | 2 | 086197acbfec4ac0c15b7e9721871aaa9e32e219 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.99e-03 | 176 | 17 | 2 | b6497324e3e52f514ce556a3fa0c3011c45dcc7b | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.99e-03 | 176 | 17 | 2 | 1510cdfcfb46ce1196a1220c07fb5f3986c81b78 | |
| ToppCell | droplet-Spleen-nan-24m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-03 | 177 | 17 | 2 | 5f20a1a875d6f85ec07b097e6afdb07c2f8f88ff | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.04e-03 | 178 | 17 | 2 | 50bb1f2c6a8d050ff2af217fd76c3b1b7b4a4a69 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-03 | 178 | 17 | 2 | be8af4d85b8835a85a168639c37857dcaa6b00bf | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-03 | 178 | 17 | 2 | 1a578d16008a450c42e73a996247ffecdc2c43f0 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-B_(AT2)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.06e-03 | 179 | 17 | 2 | 466da2bc3bfc534ffe111c8c28ece7a3cfa08051 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-B_(AT2)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.06e-03 | 179 | 17 | 2 | f4bdebb77d39e63160fbf3a85a340ce4d52b7cfd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Inner_Medullary_Collecting_Duct_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-03 | 180 | 17 | 2 | b927e7380369da6f92ba23d96103519884b70595 | |
| ToppCell | AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.10e-03 | 181 | 17 | 2 | ed0ea67f0607073aedf153f8d1073b35e46127c3 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-03 | 181 | 17 | 2 | 89c551de26de047c316c91ac1d97bdf728a33d9e | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-03 | 182 | 17 | 2 | 8b16a13d8606d21a7a9ce1175237e9b4cf832ee0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-03 | 182 | 17 | 2 | 041bc819e6cf2618bf86bce8dfe2df673f392ba3 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-03 | 182 | 17 | 2 | faf0dfa3adc2d2706b6942b5127093ccdc856447 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-03 | 182 | 17 | 2 | be8dd52898525ce6632af0adc2801944f3ac10bd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-03 | 183 | 17 | 2 | 82b84ee065fb573688d59da97a327152a1ba294c | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.15e-03 | 183 | 17 | 2 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-03 | 183 | 17 | 2 | 824ecda1219fb596a01bf5cfeee29a6daa462098 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-03 | 183 | 17 | 2 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | 2.17e-03 | 184 | 17 | 2 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.17e-03 | 184 | 17 | 2 | 2a8338e94937686a148b5433515700ca0f674058 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.17e-03 | 184 | 17 | 2 | 0ba243cbf69b4fe6ae100a7f0314317bec38026c | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-03 | 184 | 17 | 2 | 69348c9237e44f7752ac01f60e733ad41580fdb8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-03 | 185 | 17 | 2 | eb174c037e7defb015de35a30157eacf0385490a | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-03 | 185 | 17 | 2 | 3f1aa91efae2d00320d126087cce1431ad5f26ea | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-03 | 185 | 17 | 2 | 898a093757f86be3e18d2ef1f16a71f50ef81dc3 | |
| ToppCell | CV-Healthy-7|Healthy / Virus stimulation, Condition and Cluster | 2.20e-03 | 185 | 17 | 2 | 1979d189c204f4c2893e3170a514ee7d5523406c | |
| ToppCell | AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.20e-03 | 185 | 17 | 2 | 3b3268e3f99121124e33086cac88479808d31630 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-03 | 185 | 17 | 2 | add23ccccfca9374a68f127108b9a6dfe4d8cd66 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-03 | 187 | 17 | 2 | 90a1078b0303799fba5d2ca4fa12076fd75b78b1 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-03 | 187 | 17 | 2 | b93cf4dfe8ffb89348ee7bccc9f284189f7240a2 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.24e-03 | 187 | 17 | 2 | edb0ab0154542b1c0b3a2c216c4a60f0f06290b3 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-03 | 187 | 17 | 2 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-03 | 187 | 17 | 2 | 0f90bce2087aecfdbb377e6f46c6e468efbb6e28 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.24e-03 | 187 | 17 | 2 | 0277d4e54bd4d48f30241c2951a569209423fee8 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.24e-03 | 187 | 17 | 2 | 11670a85db87cbb3e78022a589632173604b0940 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-03 | 187 | 17 | 2 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-03 | 187 | 17 | 2 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-03 | 187 | 17 | 2 | 76c957b2976d38adb45e07bcf96c689442e1fc20 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-03 | 187 | 17 | 2 | 7ea8731288e2a99f45e3958590ee1d76f49ae888 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.27e-03 | 188 | 17 | 2 | 2b8d70f761eda5509f21845a87cdb3602a639dd7 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.27e-03 | 188 | 17 | 2 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.29e-03 | 189 | 17 | 2 | 7899af78b273d9c7f029d52f7e0cf6df4da41f5e | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.29e-03 | 189 | 17 | 2 | 6f2322d017b74a1757c81d6e06f50ead8c3dd0cc | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.29e-03 | 189 | 17 | 2 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.29e-03 | 189 | 17 | 2 | 926b5fa3064b501a57ba78583e8af33532add455 | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.29e-03 | 189 | 17 | 2 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-03 | 190 | 17 | 2 | d13fd234caa3fc69d8a59bc0060cdacdf716ee55 | |
| ToppCell | AT2_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 2.31e-03 | 190 | 17 | 2 | 46dfab02c1b4a403b7efc871707b6a189eefd4c4 | |
| ToppCell | Control-Epithelial-ATII|Control / Disease state, Lineage and Cell class | 2.31e-03 | 190 | 17 | 2 | d50902a3abcc18aafa36d83cc2c6e07d7f7cb197 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.31e-03 | 190 | 17 | 2 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | 368C-Epithelial_cells|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.31e-03 | 190 | 17 | 2 | 459811e88d3001816c2d89034e0921c24918c17f | |
| ToppCell | (7)_Epithelial-D_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.31e-03 | 190 | 17 | 2 | 832d6d3ad14665e50623afe1b8586ccae1a97de5 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.31e-03 | 190 | 17 | 2 | a34293601aefe5fb5c400c14091294b9ddaa195b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-03 | 190 | 17 | 2 | cc17ab84a9328124f146951c06be3eff9650d9fd | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.34e-03 | 191 | 17 | 2 | f58c578305b9cc63b71255082f9615d7c8f5f4de | |
| ToppCell | 367C-Epithelial_cells|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.34e-03 | 191 | 17 | 2 | d31975fc33779b0b3ff1a50d7c64fec8d08be4d4 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.34e-03 | 191 | 17 | 2 | 2b0d55a8e1b4ce862dd038f8e0429e8428fb8aba | |
| ToppCell | (7)_Epithelial-E_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.34e-03 | 191 | 17 | 2 | 0fc8d109d5c50957ceef5b8b8b818b0c598b1bbe | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.36e-03 | 192 | 17 | 2 | 445985fe1bcd33e4f0a1704b27988fbfc9334538 | |
| ToppCell | (7)_Epithelial-C_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.39e-03 | 193 | 17 | 2 | a3ca6ab20c8de260e410ddc14d3d202f28b9d6c2 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.39e-03 | 193 | 17 | 2 | 44839a606ae2f8e37421bda46d588189e1c943d2 | |
| Computational | Steroid hormone and heme metabolism. | 1.36e-04 | 16 | 12 | 2 | MODULE_505 | |
| Drug | C1 11-32 | 6.46e-10 | 18 | 17 | 4 | CID000443077 | |
| Drug | C11131 | 6.46e-10 | 18 | 17 | 4 | CID000443076 | |
| Drug | T4-G | 8.18e-10 | 19 | 17 | 4 | CID000152424 | |
| Drug | estriol-16-glucuronide | 1.26e-09 | 21 | 17 | 4 | CID000122281 | |
| Drug | estradiol-3-glucuronide | 1.87e-09 | 23 | 17 | 4 | CID000066651 | |
| Drug | AC1N8H7N | 2.48e-09 | 78 | 17 | 5 | CID004318740 | |
| Drug | L-idaro-1,4-lactone | 4.31e-09 | 28 | 17 | 4 | CID000078997 | |
| Drug | 7-hydroxycoumarin glucuronide | 4.99e-09 | 29 | 17 | 4 | CID000125641 | |
| Drug | UDP-N-acetylglucosamine | 5.32e-09 | 203 | 17 | 6 | CID000001167 | |
| Drug | BP-3,6-quinol | 8.59e-09 | 33 | 17 | 4 | CID000119292 | |
| Drug | AC1Q6OQG | 8.59e-09 | 33 | 17 | 4 | CID000009686 | |
| Drug | AC1NOWCJ | 1.10e-08 | 35 | 17 | 4 | CID005120112 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 1.10e-08 | 35 | 17 | 4 | CID010436171 | |
| Drug | estrone-3-glucuronide | 1.10e-08 | 35 | 17 | 4 | CID000115255 | |
| Drug | l-borneol | 1.38e-08 | 37 | 17 | 4 | CID000010049 | |
| Drug | harmol | 1.91e-08 | 40 | 17 | 4 | CID000068094 | |
| Drug | 2-AF | 2.12e-08 | 41 | 17 | 4 | CID000005800 | |
| Drug | testosterone glucuronide | 2.12e-08 | 41 | 17 | 4 | CID000108192 | |
| Drug | androsterone glucuronide | 2.58e-08 | 43 | 17 | 4 | CID000114833 | |
| Drug | 7,8-benzoquinoline | 2.58e-08 | 43 | 17 | 4 | CID000009191 | |
| Drug | MS-222 | 2.83e-08 | 44 | 17 | 4 | CID000011400 | |
| Drug | hexobarbital | 2.93e-08 | 127 | 17 | 5 | CID000003608 | |
| Drug | salicylamide | 4.05e-08 | 48 | 17 | 4 | CID000005147 | |
| Drug | oltipraz | 4.28e-08 | 137 | 17 | 5 | CID000047318 | |
| Drug | butylated hydroxytoluene | 5.31e-08 | 143 | 17 | 5 | CID000031404 | |
| Drug | AC1NQGK1 | 5.63e-08 | 52 | 17 | 4 | CID005195977 | |
| Drug | oxazepam | 6.09e-08 | 53 | 17 | 4 | CID000004616 | |
| Drug | 7-methoxycoumarin | 8.20e-08 | 57 | 17 | 4 | CID000010748 | |
| Drug | phenolphthalein | 8.80e-08 | 58 | 17 | 4 | CID000004764 | |
| Drug | urochloralic acid | 9.44e-08 | 59 | 17 | 4 | CID003036914 | |
| Drug | 4-hydroxybiphenyl | 9.44e-08 | 59 | 17 | 4 | CID000007103 | |
| Drug | 4-hydroxyestrone | 9.44e-08 | 59 | 17 | 4 | CID000018418 | |
| Drug | SN-38G | 9.44e-08 | 59 | 17 | 4 | CID000443154 | |
| Drug | acetaminophen glucuronide | 9.44e-08 | 59 | 17 | 4 | CID000083944 | |
| Drug | UDP-alpha-d-xylopyranose | 1.01e-07 | 60 | 17 | 4 | CID000001165 | |
| Drug | 3-OHBaP | 1.23e-07 | 63 | 17 | 4 | CID000025890 | |
| Drug | glucosiduronate | 1.30e-07 | 171 | 17 | 5 | CID000000610 | |
| Drug | Meldola | 1.68e-07 | 68 | 17 | 4 | CID000081507 | |
| Drug | methoxyresorufin | 1.78e-07 | 69 | 17 | 4 | CID000119220 | |
| Drug | 2,2,2-trichloroethanol | 2.24e-07 | 73 | 17 | 4 | CID000008259 | |
| Drug | eugenol | 2.24e-07 | 73 | 17 | 4 | CID000003314 | |
| Drug | 7-hydroxycoumarin | 2.50e-07 | 75 | 17 | 4 | CID005281426 | |
| Drug | 2-butyl-6-methoxyphenol | 2.62e-07 | 197 | 17 | 5 | CID011954184 | |
| Drug | 16-epiestriol | 2.78e-07 | 77 | 17 | 4 | CID000003269 | |
| Drug | benzyloxyresorufin | 2.93e-07 | 78 | 17 | 4 | CID000114982 | |
| Drug | acridine | 3.42e-07 | 81 | 17 | 4 | CID000009215 | |
| Drug | 5 alpha-androstane | 3.96e-07 | 84 | 17 | 4 | CID000094144 | |
| Drug | 7-ethoxycoumarin | 4.35e-07 | 86 | 17 | 4 | CID000035703 | |
| Drug | pentoxyresorufin | 4.56e-07 | 87 | 17 | 4 | CID000107683 | |
| Drug | menthol | 4.56e-07 | 87 | 17 | 4 | CID000001254 | |
| Drug | buthionine sulfoximine | 5.53e-07 | 229 | 17 | 5 | CID000021157 | |
| Drug | 4-aminobiphenyl | 5.71e-07 | 92 | 17 | 4 | CID000007102 | |
| Drug | p-nitroanisole | 5.71e-07 | 92 | 17 | 4 | CID000007485 | |
| Drug | 2-naphthol | 5.96e-07 | 93 | 17 | 4 | CID000008663 | |
| Drug | UDP - Na | 6.28e-07 | 235 | 17 | 5 | CID000001158 | |
| Drug | 2-methoxyestradiol | 6.41e-07 | 236 | 17 | 5 | CID000001573 | |
| Drug | ethoxyresorufin | 6.49e-07 | 95 | 17 | 4 | CID000003294 | |
| Drug | DCNB | 6.49e-07 | 95 | 17 | 4 | CID000007443 | |
| Drug | DB04103 | 7.06e-07 | 97 | 17 | 4 | CID004469987 | |
| Drug | 1-naphthol | 7.36e-07 | 98 | 17 | 4 | CID000007005 | |
| Drug | UDP-glucose | 8.03e-07 | 247 | 17 | 5 | CID000001166 | |
| Drug | 3-hydroxyandrostan-17-one | 8.64e-07 | 102 | 17 | 4 | CID000000225 | |
| Drug | morphine hydrochloride | 8.75e-07 | 481 | 17 | 6 | CID000004253 | |
| Drug | chrysin | 1.01e-06 | 106 | 17 | 4 | CID005281607 | |
| Drug | fluconazole | 1.05e-06 | 107 | 17 | 4 | CID000003365 | |
| Drug | 2-naphthylamine | 1.17e-06 | 110 | 17 | 4 | CID000007057 | |
| Drug | acetaminophen | 1.24e-06 | 270 | 17 | 5 | CID000001983 | |
| Drug | lithocholic acid | 1.45e-06 | 116 | 17 | 4 | CID000009903 | |
| Drug | ethoxyquin | 1.45e-06 | 116 | 17 | 4 | CID000003293 | |
| Drug | AC1Q7AUJ | 1.50e-06 | 117 | 17 | 4 | CID000003303 | |
| Drug | fibrates | 1.55e-06 | 118 | 17 | 4 | CID000002797 | |
| Drug | alpha-naphthoflavone | 1.55e-06 | 118 | 17 | 4 | CID000011790 | |
| Drug | benzphetamine | 1.60e-06 | 119 | 17 | 4 | CID000002341 | |
| Drug | glutathione reduced | 1.61e-06 | 534 | 17 | 6 | CID000000745 | |
| Drug | silibinin | 1.62e-06 | 285 | 17 | 5 | CID000005213 | |
| Drug | AC1L1FK5 | 2.21e-06 | 129 | 17 | 4 | CID000003272 | |
| Drug | 4-methylumbelliferone | 2.42e-06 | 132 | 17 | 4 | CID003364573 | |
| Drug | aniline | 3.24e-06 | 142 | 17 | 4 | CID000006115 | |
| Drug | 2 E1 | 3.52e-06 | 145 | 17 | 4 | CID006102788 | |
| Drug | arabinosyluracil | 4.69e-06 | 354 | 17 | 5 | CID000001177 | |
| Drug | benzo(a)pyrene | 4.95e-06 | 358 | 17 | 5 | CID000002336 | |
| Drug | disulfiram | 4.95e-06 | 158 | 17 | 4 | CID000003117 | |
| Drug | phenobarbital | 5.09e-06 | 360 | 17 | 5 | CID000004763 | |
| Drug | AC1LCF1F | 5.34e-06 | 161 | 17 | 4 | CID000627275 | |
| Drug | al-Badry | 5.88e-06 | 165 | 17 | 4 | CID000004545 | |
| Drug | estrone-d4 | 6.32e-06 | 168 | 17 | 4 | CID000000698 | |
| Drug | aminopyrine | 6.77e-06 | 171 | 17 | 4 | CID000006009 | |
| Drug | 4-nitrophenol | 7.76e-06 | 177 | 17 | 4 | CID000000980 | |
| Drug | 2-hydroxyestriol | 7.86e-06 | 6 | 17 | 2 | CID000014688 | |
| Drug | SN-38 | 9.05e-06 | 184 | 17 | 4 | CID000104842 | |
| Drug | sodium cholate | 9.34e-06 | 408 | 17 | 5 | CID000000303 | |
| Drug | uridine 5'-diphosphoglucuronic acid | 1.01e-05 | 189 | 17 | 4 | CID000000390 | |
| Drug | DNCB | 1.01e-05 | 189 | 17 | 4 | CID000000006 | |
| Drug | dimethylnitrosamine | 1.16e-05 | 196 | 17 | 4 | CID000006124 | |
| Drug | beta-naphthoflavone | 1.26e-05 | 200 | 17 | 4 | CID000002361 | |
| Drug | N'-nitrosonornicotine | 1.34e-05 | 63 | 17 | 3 | CID000027919 | |
| Drug | Aroclor 1254 | 1.61e-05 | 213 | 17 | 4 | CID000040470 | |
| Drug | 3-methylcholanthrene | 2.21e-05 | 231 | 17 | 4 | CID000001674 | |
| Drug | 3 -hydroxypregn-5-en-20-one | 2.49e-05 | 238 | 17 | 4 | CID000001027 | |
| Drug | NADP(H | 3.20e-05 | 527 | 17 | 5 | CID000000930 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 1.33e-08 | 9 | 17 | 3 | EFO_0600040 | |
| Disease | phosphatidylcholine 36:4 measurement | 1.29e-07 | 18 | 17 | 3 | EFO_0010382 | |
| Disease | vanillylmandelate (VMA) measurement | 6.55e-06 | 7 | 17 | 2 | EFO_0800119 | |
| Disease | X-19141 measurement | 2.43e-05 | 13 | 17 | 2 | EFO_0800799 | |
| Disease | X-24947 measurement | 7.17e-05 | 22 | 17 | 2 | EFO_0800910 | |
| Disease | vitamin D deficiency | 2.06e-04 | 37 | 17 | 2 | EFO_0003762 | |
| Disease | diverticular disease | 3.16e-04 | 236 | 17 | 3 | EFO_0009959 | |
| Disease | disease progression measurement | 5.60e-04 | 61 | 17 | 2 | EFO_0008336 | |
| Disease | vitamin D measurement | 8.84e-04 | 336 | 17 | 3 | EFO_0004631 | |
| Disease | serum gamma-glutamyl transferase measurement | 1.58e-03 | 914 | 17 | 4 | EFO_0004532 | |
| Disease | metabolite measurement | 3.79e-03 | 560 | 17 | 3 | EFO_0004725 | |
| Disease | testosterone measurement | 5.26e-03 | 1275 | 17 | 4 | EFO_0004908 | |
| Disease | asthma | 8.56e-03 | 751 | 17 | 3 | MONDO_0004979 | |
| Disease | urinary metabolite measurement | 8.60e-03 | 245 | 17 | 2 | EFO_0005116 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SFKWFDNSNMTFDKW | 101 | Q8IX05 | |
| QQFWAMFLKKAAYSW | 906 | Q99758 | |
| WGKWNLNPQQFYTMF | 401 | Q09328 | |
| TWPWKNEDFNQKFTQ | 266 | Q9C000 | |
| FDKNGNMMDWWSNFS | 626 | Q495T6 | |
| FMSGVNKEKQFWRWF | 111 | Q9H0C2 | |
| WEDFKQNTPFLNWKA | 396 | Q6E0U4 | |
| KKKMAWWESNNYQSF | 671 | Q86WJ1 | |
| AESENFAFWQDMKWK | 591 | Q9BZF2 | |
| FAFWQDMKWKNKFWG | 596 | Q9BZF2 | |
| WKFDSQERMFWNLMP | 631 | P51692 | |
| PFFSVQMWSVWDKNA | 296 | P47901 | |
| DQPFFWNFKQMWDSK | 291 | Q96P53 | |
| EFWFQIFDMKKWDQF | 221 | P06133 | |
| DFWFQMSDMKKWDQF | 221 | O75310 | |
| FWFQIFNMKKWDQFY | 221 | P36537 | |
| DFWFQMCDMKKWDQF | 221 | Q9BY64 | |
| EQPFFWNIKQMWDTK | 291 | Q8IWB7 |